LSA
L & S Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,500
| Closed | -$568K | – | 286 |
|
|
2021
Q4 | $568K | Sell |
7,500
-8,006
| -52% | -$606K | 0.06% | 212 |
|
|
2021
Q3 | $1.74M | Buy |
15,506
+5,948
| +62% | +$666K | 0.19% | 154 |
|
|
2021
Q2 | $1.55M | Sell |
9,558
-4,032
| -30% | -$653K | 0.17% | 179 |
|
|
2021
Q1 | $1.66M | Sell |
13,590
-39
| -0.3% | -$4.75K | 0.19% | 174 |
|
|
2020
Q4 | $2.09M | Buy |
13,629
+3,377
| +33% | +$517K | 0.24% | 145 |
|
|
2020
Q3 | $857K | Sell |
10,252
-373
| -4% | -$31.2K | 0.12% | 195 |
|
|
2020
Q2 | $781K | Buy |
+10,625
| New | +$781K | 0.12% | 188 |
|
|
2018
Q4 | – | Sell |
-11,070
| Closed | -$491K | – | 306 |
|
|
2018
Q3 | $491K | Sell |
11,070
-7,215
| -39% | -$320K | 0.06% | 221 |
|
|
2018
Q2 | $1.07M | Buy |
+18,285
| New | +$1.07M | 0.18% | 130 |
|